Comparison between Aptus Pharma IPO and K K Silk Mills IPO.
Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while K K Silk Mills IPO is a SME Bookbuilding proposed to list at BSE SME.
| Aptus Pharma IPO | K K Silk Mills IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Axial Capital Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Market-Hub Stock Broking Pvt.Ltd. | Aftertrade Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aptus Pharma IPO is up to ₹12.36 Cr whereas the issue size of the K K Silk Mills IPO is up to ₹27.08 Cr. The final issue price of Aptus Pharma IPO is ₹70.00 per share and of K K Silk Mills IPO is ₹38.00 per share.
| Aptus Pharma IPO | K K Silk Mills IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹36.00 per share |
| Issue Price (Upper) | ₹70.00 per share | ₹38.00 per share |
| Issue Price (Final) | ₹70.00 per share | ₹38.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | 17,66,000 shares | 71,25,000 shares |
| Fresh Issue Size (Amount) | up to ₹12.36 Cr | up to ₹27.08 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,66,000 shares | 71,25,000 shares |
| Issue Size Total (Amount) | up to ₹12.36 Cr | up to ₹27.08 Cr |
Aptus Pharma IPO opens on Sep 23, 2025, while K K Silk Mills IPO opens on Nov 26, 2025. The closing date of Aptus Pharma IPO and K K Silk Mills IPO is Sep 25, 2025, and Nov 28, 2025, respectively.
| Aptus Pharma IPO | K K Silk Mills IPO | |
|---|---|---|
| Anchor Bid Date | Sep 22, 2025 | Nov 25, 2025 |
| Issue Open | Sep 23, 2025 | Nov 26, 2025 |
| Issue Close | Sep 25, 2025 | Nov 28, 2025 |
| Basis Of Allotment (Tentative) | Sep 26, 2025 | Dec 01, 2025 |
| Initiation of Refunds (Tentative) | Sep 29, 2025 | Dec 02, 2025 |
| Credit of Share (Tentative) | Sep 29, 2025 | Dec 02, 2025 |
| Listing date (Tentative) | Sep 30, 2025 | Dec 03, 2025 |
| Anchor Lockin End date 1 | Oct 26, 2025 | Dec 31, 2025 |
| Anchor Lockin End date 2 | Dec 25, 2025 | Mar 01, 2026 |
Aptus Pharma IPO P/E ratio is 11.29, as compared to K K Silk Mills IPO P/E ratio of 12.12.
| Aptus Pharma IPO | K K Silk Mills IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Aptus Pharma Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)K K Silk Mills Ltd.'s revenue increased by 16% and profit after tax (PAT) rose by 107% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.89 | 66.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.29 | 12.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹48.02 Cr. | ₹85.27 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.50% | 11.79% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.66% | 12.44% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.49 | 1.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.20 | ₹3.13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 44.50% | 11.79% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aptus Pharma IPO Retail Individual Investors (RII) are offered 6,20,000 shares while in K K Silk Mills IPO retail investors are offered 6,20,000 shares. Qualified Institutional Buyers (QIB) are offered 3,52,000 shares in Aptus Pharma IPO and 72,000 shares in K K Silk Mills IPO.
| Aptus Pharma IPO | K K Silk Mills IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,28,000 shares | 0 shares |
| Market Maker Reservation | 94,000 shares | 3,75,000 shares |
| QIB | 3,52,000 shares | 72,000 shares |
| NII | 2,66,000 shares | 35,25,000 shares |
| RII | 6,20,000 shares | 35,28,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 17,66,000 shares | 71,25,000 shares |
Aptus Pharma IPO subscribed 22.27x in total, whereas K K Silk Mills IPO subscribed 5.66x.
| Aptus Pharma IPO | K K Silk Mills IPO | |
|---|---|---|
| QIB (times) | 1.24x | 5.71x |
| NII (times) | 28.75x | 1.60x |
| Big NII (times) | 30.64x | 0.75x |
| Small NII (times) | 24.93x | 3.29x |
| RII (times) | 31.43x | 9.72x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 22.27x | 5.66x |
